ReWalk Robotics Ltd. (LFWD)
NASDAQ: LFWD · IEX Real-Time Price · USD
4.950
-0.050 (-1.00%)
Apr 18, 2024, 2:18 PM EDT - Market open
ReWalk Robotics Market Cap
ReWalk Robotics has a market cap or net worth of $42.49 million as of April 18, 2024. Its market cap has increased by 7.83% in one year.
Market Cap
42.49M
Enterprise Value
16.31M
1-Year Change
7.83%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since September 12, 2014, ReWalk Robotics's market cap has decreased from $294.80M to $42.49M, a decrease of -85.59%. That is a compound annual growth rate of -18.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 42.50M | 0.24% |
Apr 16, 2024 | 42.40M | -0.24% |
Apr 15, 2024 | 42.50M | -6.59% |
Apr 12, 2024 | 45.50M | 4.60% |
Apr 11, 2024 | 43.50M | 1.64% |
Apr 10, 2024 | 42.80M | -0.47% |
Apr 9, 2024 | 43.00M | -3.59% |
Apr 8, 2024 | 44.60M | -5.11% |
Apr 5, 2024 | 47.00M | -1.47% |
Apr 4, 2024 | 47.70M | 3.25% |
Apr 3, 2024 | 46.20M | 6.70% |
Apr 2, 2024 | 43.30M | 0.23% |
Apr 1, 2024 | 43.20M | -2.70% |
Mar 28, 2024 | 44.40M | 0.91% |
Mar 27, 2024 | 44.00M | -4.14% |
Mar 26, 2024 | 45.90M | -4.97% |
Mar 25, 2024 | 48.30M | 7.33% |
Mar 22, 2024 | 45.00M | 12.22% |
Mar 21, 2024 | 40.10M | -2.67% |
Mar 20, 2024 | 41.20M | 10.75% |
Mar 19, 2024 | 37.20M | 5.68% |
Mar 18, 2024 | 35.20M | -12.22% |
Mar 15, 2024 | 40.10M | 12.01% |
Mar 14, 2024 | 35.80M | -4.53% |
Mar 13, 2024 | 37.50M | -12.38% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Rockwell Medical | 43.42M |
IN8bio | 43.29M |
Quince Therapeutics | 43.22M |
Ocuphire Pharma | 43.18M |
Aspira Women's Health | 43.08M |
SAB Biotherapeutics | 42.44M |
Xilio Therapeutics | 42.40M |
Carmell Therapeutics | 42.34M |